Frazier Financial Advisors, LLC Astrazeneca PLC Transaction History
Frazier Financial Advisors, LLC
- $129 Billion
- Q3 2024
A detailed history of Frazier Financial Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 935 shares of AZN stock, worth $60,485. This represents 0.06% of its overall portfolio holdings.
Number of Shares
935
Previous 1,236
24.35%
Holding current value
$60,485
Previous $96.4 Million
24.43%
% of portfolio
0.06%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,347Shares Held
491MCall Options Held
5MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.2 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$2.76 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.62 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.37 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.14 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $200B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...